Loading data
VNRXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.73 m USD | 1.23 m USD | 775.3 k USD | 306.39 k USD | 90.04 k USD |
| Research and development expense | 10.08 m USD | 14.41 m USD | 19.55 m USD | 15.33 m USD | 13.02 m USD |
| Operating profit | -21.74 m USD | -27.02 m USD | -35.99 m USD | -31.78 m USD | -28.33 m USD |
| Net income (reported basis) | -23.36 m USD | -26.97 m USD | -35.68 m USD | -30.6 m USD | -26.99 m USD |
| Net income attributable to common shareholders | — | -26.97 m USD | -35.32 m USD | — | — |
| Diluted earnings per share | — | -0.31 USD/share | -0.5 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.